Long-Term Outcomes of Behçet’s Syndrome-Related Uveitis: A Monocentric Italian Experience

Figure 2

Timeline graph illustrating the different biologic treatments administered to our patients over time. List of abbreviations: ADA: adalimumab; ANA: anakinra; CAN: canakinumab; ETN: etanercept; GOL: golimumab; IFX: infliximab; TCZ: tocilizumab.